Home - Medical Policies - Alabama
- Advanced Imaging
- Autism Spectrum Mandate
- Behavioral Health
- Blue Advantage Policies
- Chronic Condition Management
- Genetic Testing
- HealthSmartRx Medical Drug Copay Maximizer Program
- Hemophilia Drugs
- Medical Policies
- Provider-Administered Drug Policies (Excluding Oncology)
- Provider-Administered Oncology Drug Policies
- Radiation Therapy
- Self-Administered Drug Policies
- Transgender Services
Current Genetic Testing Policies
Blue Cross and Blue Shield of Alabama partners with AIM Specialty Health® (AIM), an independent company that administers genetic testing solutions for our customers.
Third Party Disclaimer
You are about to leave Blue Cross and Blue Shield of Alabama’s website and enter a website operated by AIM . AIM is our business associate and is an independent company that provides diagnostic testing, information and services. AIM has agreed to follow Blue Cross' privacy and security policies regarding the confidentiality and protection of your personal health information.
To continue to the AIM Specialty Health® website, click "Accept” below.
Genetic Testing
For dates of service March 1, 2020, through December 31, 2021, the following policies supersede AIM Clinical Appropriateness Guidelines for Genetic Testing for Reproductive Carrier Screening and Prenatal Diagnosis: